NIH Halts Trial of Convalescent Plasma for Mild COVID-19

According to the NIH, patients in a clinical trial with mild to moderate COVID-19 symptoms did not benefit from convalescent plasma treatment.

Toplista

Több toplistás hír

Hirdetés